BACKGROUND: Here, we report a laboratory-based study of Streptococcus pneumoniae recovered from patients with meningitis in Rio de Janeiro State, Brazil. METHODS: The aim of this study was to determine the evolution of β-lactam resistance, antimicrobial susceptibility pattern, serotypes, and genetic diversity of S. pneumoniae, isolated from meningitis patients between 2000 and 2008. RESULTS: A total of 264 S. pneumoniae recovered from patients between 2000 and 2008 were included. Susceptibility testing (E-test) of S. pneumoniae showed resistance to penicillin, ceftriaxone, oxacillin, cotrimoxazole, tetracycline, ofloxacin, erythromycin, chloramphenicol, and rifampicin. Penicillin resistance (PEN-R, minimal inhibitory concentration [MIC] ≥ 0.12 μg/mL) increased from 8% of isolates in 2000-2002, to 12% in 2003-2005, and to 20% in 2006-2008. Ceftriaxone resistance (MIC ≥ 1.0 μg/mL) was detected among some PEN-R isolates (13%) from 2004 onward. Within the PEN-R isolates, serotypes that are included in 10-valent pneumococcal conjugate vaccine predominated (90%), and resistance was detected mostly in isolates of serotypes 14 (61%), 23F (16%), 6B (10%), and 19F (3%). Multilocus sequence typing showed that 52% of the PEN-R isolates, and 89% of those with MICs ≥ 0.5 μg/mL, were sequence type (ST)-156 or single-locus variants of this ST (ST-557 or ST-4388); all of these isolates were serotype 14 and were assigned to the Spain-3 clone. CONCLUSIONS: β-lactam resistance increased recently among cerebrospinal fluid isolates and was mainly due to the surge of the ST-4388, a previously undescribed gki single-locus variants of ST-156. Regional surveillance is shown to be essential to provide optimal antimicrobial therapy, monitor highly successful clones, and formulate adequate vaccination strategy.
BACKGROUND: Here, we report a laboratory-based study of Streptococcus pneumoniae recovered from patients with meningitis in Rio de Janeiro State, Brazil. METHODS: The aim of this study was to determine the evolution of β-lactam resistance, antimicrobial susceptibility pattern, serotypes, and genetic diversity of S. pneumoniae, isolated from meningitispatients between 2000 and 2008. RESULTS: A total of 264 S. pneumoniae recovered from patients between 2000 and 2008 were included. Susceptibility testing (E-test) of S. pneumoniae showed resistance to penicillin, ceftriaxone, oxacillin, cotrimoxazole, tetracycline, ofloxacin, erythromycin, chloramphenicol, and rifampicin. Penicillin resistance (PEN-R, minimal inhibitory concentration [MIC] ≥ 0.12 μg/mL) increased from 8% of isolates in 2000-2002, to 12% in 2003-2005, and to 20% in 2006-2008. Ceftriaxone resistance (MIC ≥ 1.0 μg/mL) was detected among some PEN-R isolates (13%) from 2004 onward. Within the PEN-R isolates, serotypes that are included in 10-valent pneumococcal conjugate vaccine predominated (90%), and resistance was detected mostly in isolates of serotypes 14 (61%), 23F (16%), 6B (10%), and 19F (3%). Multilocus sequence typing showed that 52% of the PEN-R isolates, and 89% of those with MICs ≥ 0.5 μg/mL, were sequence type (ST)-156 or single-locus variants of this ST (ST-557 or ST-4388); all of these isolates were serotype 14 and were assigned to the Spain-3 clone. CONCLUSIONS: β-lactam resistance increased recently among cerebrospinal fluid isolates and was mainly due to the surge of the ST-4388, a previously undescribed gki single-locus variants of ST-156. Regional surveillance is shown to be essential to provide optimal antimicrobial therapy, monitor highly successful clones, and formulate adequate vaccination strategy.
Authors: Helena Zemlicková; M Inês Crisóstomo; Maria C Brandileone; Teresa Camou; Elisabeth Castañeda; Alejandra Corso; Gabriela Echániz-Aviles; Mónika Pásztor; Alexander Tomasz Journal: Microb Drug Resist Date: 2005 Impact factor: 3.431
Authors: L M Teixeira; M G Carvalho; T M Castineiras; S A Fracalanzza; A S Levin; R R Facklam Journal: Adv Exp Med Biol Date: 1997 Impact factor: 2.622
Authors: A Tomasz; A Corso; E P Severina; G Echániz-Aviles; M C Brandileone; T Camou; E Castañeda; O Figueroa; A Rossi; J L Di Fabio Journal: Microb Drug Resist Date: 1998 Impact factor: 3.431
Authors: Tatiana C A Pinto; Aline R V Souza; Sandrine E C M de Pina; Natália S Costa; Armando A Borges Neto; Felipe P G Neves; Vânia L C Merquior; Cícero A G Dias; José M Peralta; Lúcia M Teixeira Journal: J Clin Microbiol Date: 2013-07-24 Impact factor: 5.948
Authors: Juliana Caierão; Paulina Hawkins; Fernando Hayashi Sant'anna; Gabriela Rosa da Cunha; Pedro Alves d'Azevedo; Lesley McGee; Cícero Dias Journal: PLoS One Date: 2014-10-30 Impact factor: 3.240
Authors: Tatiana C A Pinto; Fabíola C O Kegele; Cícero A G Dias; Rosana R Barros; José M Peralta; Vânia L C Merquior; Maria da Gloria Carvalho; Sopio Chochua; Paulina Hawkins; Lesley McGee; Lucia M Teixeira Journal: Antimicrob Agents Chemother Date: 2016-10-21 Impact factor: 5.191
Authors: Natália S Costa; Tatiana C A Pinto; Vânia L C Merquior; Luciana F S Castro; Filomena S P da Rocha; Jaqueline M Morais; José M Peralta; Lúcia M Teixeira Journal: PLoS One Date: 2016-07-08 Impact factor: 3.240